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During respiratory syncytial virus (RSV) infection CD8+ T cells both assist in viral
clearance and contribute to immunopathology. CD8+ T cells recognize viral peptides pre-
sented by dendritic cells (DCs), which can directly present viral antigens when infected or,
alternatively, “cross-present” antigens after endocytosis of dead or dying infected cells.
Mouse CD8α+ and CD103+ DCs excel at cross-presentation, in part because they express
the receptor DNGR-1 that detects dead cells by binding to exposed F-actin and routes inter-
nalized cell debris into the cross-presentation pathway. As RSV causes death in infected
epithelial cells, we tested whether cross-presentation via DNGR-1 is necessary for CD8+
T-cell responses to the virus. DNGR-1-deficient or wild-type mice were intranasally inoc-
ulated with RSV and the magnitude of RSV-specific CD8+ T-cell induction was measured.
We found that during live RSV infection, cross-presentation via DNGR-1 did not have
a major role in the generation of RSV–specific CD8+ T-cell responses. However, after
intranasal immunization with dead cells infected with RSV, a dependence on DNGR-1
for RSV-specific CD8+ T-cell responses was observed, confirming the ascribed role of the
receptor. Thus, direct presentation by DCs may be the major pathway initiating CD8+
T-cell responses to RSV, while DNGR-1-dependent cross-presentation has no detectable
role.
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Introduction
Respiratory syncytial virus (RSV) is an important respiratory
virus of the single-stranded RNA virus family Paramyxoviridae.
RSV disease burden is estimated at 64 million cases and up to
160,000 deaths every year worldwide (www.who.int). While RSV
disease manifests as a simple common cold in the majority of
cases, between 2 and 3% of children develop severe bronchioli-
tis. Although most of these children recover, they have a greater
risk of developing recurrent wheeze and asthma-like symptoms
in later childhood [1, 2]. RSV infection induces a robust virus-
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specific CD8+ T-cell response. These T cells play a key role in
viral clearance by destroying infected cells [3] although, in mouse
models, they also contribute to lung immunopathology following
RSV infection [1, 4, 5].
Antigen processing and presentation of peptides onMHC class I
(MHC-I) is crucial for CD8+ T-cell responses to RSV and other
viruses. The classical pathway, whereby peptides from the cytosol
are loaded onto MHC-I molecules in the ER and transported to
the cell surface, is thought to be the major mechanism by which
viral antigens are displayed on the surface of infected cells [6].
However, uninfected cells can also present viral antigens in some
instances. This is termed “cross-presentation” and involves anti-
gens released from virally infected cells, often in the form of
debris of lysed cells, being taken up by bystander cells through
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endocytosis or phagocytosis and then diverted into the MHC-I
presentation pathway [6]. The ability to cross-present exogenous
antigens is particularly well developed in dendritic cells (DCs).
DCs are professional antigen presenting cells (APCs) that have the
ability to take up antigen in the periphery and then migrate to
the lymph node where they can present antigen to na¨ıve T cells.
Cross-presentation has presumably evolved to ensure that DCs can
present viral antigens to CD8+ T cells and prime cytotoxic T lym-
phocytes (CTLs) even in situations when they are not themselves
infected or where viruses encode inhibitors of endogenous antigen
processing.
Several distinct subsets of DCs are found across tissues in both
mouse and man but it is unclear how their dynamics change
during viral infection. In mouse models of RSV infection, lung
CD103+ and CD11b+ DCs migrate to the lymph nodes [7, 8] while
monocyte-derived DCs migrate into the infected lungs [9–11].
Lung CD103+ DCs are similar to lymphoid tissue-resident CD8α+
DCs in having a superior ability to cross-present antigens to CD8+
T cells [12–14]. The two DC subtypes are ontogenetically related
and share the ability to avidly phagocytose dead or dying cells and
cross-present antigens extracted from the phagocytosed material.
This is partly dependent on the C-type lectin receptor, DNGR-1
(Dendritic cell NK Lectin Group Receptor 1) (also known as
CLEC9A), which is uniquely expressed by CD103+ and CD8α+
DCs and their human equivalents [15–19]. DNGR-1 binds F-actin,
which is exposed by dying cells at the point when they lose
membrane integrity [20, 21]. Upon recognition of F-actin, DNGR-1
signals to prevent phagosomal maturation and this facilitates
antigen preservation and subsequent cross-presentation, thereby
favoring CD8+ T-cell responses against antigens present in the
cellular debris, including ones of viral origin [22–24].
RSV infection induces cell death and syncytia formation [1, 25]
but it is currently not known whether virus-induced cell death
influences the initiation and magnitude of the ensuing immune
response. Our work aimed to elucidate whether DNGR-1 and,
by inference, cell death contributes to CD8+ priming in vivo
during RSV infection. We found that DNGR-1-deficient mice
mount reduced virus-specific CD8+ T-cell responses to intranasal
inoculation with dead RSV-infected cells. However, upon live
virus infection, RSV-specific CD8+ T-cell responses are equivalent
between DNGR-1 knockout (KO) and wild-type (WT) mice. Thus,
cross-presentation of epitopes from dead RSV-infected cells via
DNGR-1 can influence the magnitude of CD8+ T-cell responses but
is not crucial during RSV infection, suggesting that direct presen-
tation of RSV epitopes by infected DCs may be the main pathway
for CD8+ T-cell induction during RSV infection.
Results
DNGR-1 plays no role in viral load, cell infiltration or
cytokine production during RSV infection
In order to evaluate whether DNGR-1 KO mice have any defects
in innate anti-RSV immunity, WT and DNGR-1 KO mice were
intranasally inoculated with 1 × 106 focus forming units (FFU) of
RSV on day 0. Copies of RSV L gene RNAwere detected on day 1, 4
(peak), and 8 post infection (p.i.) using qPCR (Fig. 1A). There was
no noticeable difference in viral replication or clearance between
WT and DNGR-1 KO mice. In order to assess lung inflammation,
the cellular infiltration into the bronchoalveolar lavage (BAL) was
investigated. The total number of cells in the BAL was not different
between DNGR-1 KO andWTmice (Fig. 1B). Furthermore, in both
DNGR-1 KO and WT mice, accumulation of neutrophils in the BAL
was detected at day 1 p.i. and lymphocytes were detectable at day
4 and were further increased by day 8 p.i. (Fig. 1B). The frequency
of macrophages was not different between DNGR-1 KO and WT
mice and no eosinophils were detected in any BAL samples at
any time point (data not shown). In addition, early inflammatory
mediators (IFN-α, CXCL10, and IL-6) were analyzed in the BAL
on day 1 and 4 and all were detected at similar levels in WT
and DNGR-1 KO mice (Fig. 1C). Thus, DNGR1 expression does
not appear to be essential for the early immune response or viral
clearance during RSV infection.
RSV pathology and T-cell infiltration to the lung is not
dependent on DNGR-1
In the mouse model, RSV disease severity as measured by weight
loss has been linked to a potent response by RSV-specific T cells
[1, 3, 26]. As DNGR-1 has been shown to mediate cross-priming
of CTLs during virus infection [23, 24], the lack of DNGR-1 might
lead to reduced T-cell priming and therefore decreased disease
severity. RSV infected WT mice showed weight loss starting on
day 5 p.i. with about 15% weight loss on day 6 and recovery
on day 8 p.i. (Fig. 2A). Contrary to our hypothesis, DNGR-1 KO
mice showed equal weight loss to the WT mice after RSV infection
(Fig. 2A). In addition, total lung cell numbers after RSV infection
were equivalent between DNGR-1 KO and WT mice (Fig. 2B) and
there was no difference in frequency and absolute number of CD8+
T cells (Fig. 2C and E). The absolute numbers of CD4+ T cells in the
lung did not increase after infection (Fig. 2C and D) as previously
shown [27, 28]. Finally, no difference in RSV-specific antibodies
was found after primary or secondary RSV infection in DNGR-1 KO
mice compared with littermate controls (data not shown). Thus,
the absence of DNGR-1 does not affect the influx of T cells into
the lungs during RSV infection or the overall pathology.
DNGR-1 deficiency does not affect the induction of
RSV-specific CD8+ T-cell responses
We further examined whether the RSV-specific CD8+ T-cell
response was affected. First, we quantified the frequency of CD8+
T cells specific for an immunodominant epitope derived from the
M2 protein [29, 30] by using Alexa Fluor-647 conjugated MHC
class I tetramer-M282-90 complexes (Fig. 3A). Tetramer+CD8+
T cells were detected in the BAL and lungs at approximately 25%
of CD8+ T cells on day 8 post RSV infection (the peak of T-cell
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Figure 1. Viral load, cellular infiltration,
and cytokine production into the BAL
after RSV infection are not different in
DNGR-1 KO mice compared with WT
mice. Mice were intranasally infected
with 106 FFU of RSV A2. (A) Viral load
was determined by measuring copies of
RSV L gene RNA on day 1, 4, and 8 post
infection (p.i.). The detection limit for
the copy numbers of L gene according
to the standard curve is indicated by the
dotted line. Data are presented as the
mean ± SEM (n = 4–5 mice per group)
and are from a single experiment rep-
resentative of at least two independent
experiments. (B) Bronchoalveolar lavage
(BAL) was obtained from naive or RSV-
infected WT or DNGR-1 KO mice on day
1, 4, and 8 p.i. The total number of BAL
cells was quantified and the frequency
of neutrophils and lymphocytes were
determinedusing differential cell count-
ing of H&E stained cytospin slides. Data
are shown as mean ± SEM of 8–22 mice
per group pooled from three to four indi-
vidual experiments. (C) Levels of IFN-α,
CXCL10, and IL-6 in the BAL fluid were
determined using ELISA. Data are pre-
sented as the mean + SEM of 6–8 mice
per group pooled from two experiments.
Differences were not statistically signif-
icant by two-tailed, unpaired, nonpara-
metric Mann–Whitney test.
responses) but this was similar between DNGR-1 KO and WT mice
(data not shown and Fig. 3A and B). We further analyzed the RSV
specific CD8+ T-cell response on day 8 p.i. by quantifying IFN-γ+
CD8+ T cells in the lung following 4 h ex vivo restimulation
with the immunodominant peptide M282-90 (Fig. 4A). Few IFN-γ+
CD8+ T cells were detected after restimulation with medium alone
(Fig. 4) or with the irrelevant DbM187–195 RSV peptide (data not
shown; see Fig. 5). However, around 40% of the CD8+ T cells
produced IFN-γ after stimulation with M282-90 peptide but, impor-
tantly, there was no difference between the DNGR-1 KO and WT
mice (Fig. 4B). In addition, IFN-γ levels in the BAL were examined
at day 8 p.i. and similar IFN-γ production was detected in DNGR-1
KO and WT mice (Fig. 4C). Furthermore, total T-cell responses
were quantified by restimulating lung single-cell suspensions with
M282-90 peptide at various concentrations (5 ng/ml; 0.5 ng/ml;
0.05 ng/ml) or with RSV (MOI of 1) and measuring IFN-γ
levels in culture supernatants, which again showed no difference
between DNGR-1-deficient and WT mice (Fig. 5A).
The above analysis focused exclusively on the immunodomi-
nant epitope M282-90. We performed additional restimulations of
lung cells from RSV infected mice with F85–93 and F93–106 peptides
corresponding to two subdominant epitopes that, like M282-90,
are presented by H-2Kd [31, 32]. Compared with restimulation
in medium alone, F peptides induced IFN-γ production from lung
cells above background although this response was much weaker
than that seen with M2 restimulations. Importantly, there were no
differences in the response to either F peptide between DNGR-1
KO and WT mice (Fig. 5B). Taken together, these data indicate
that DNGR-1 expression is not critical for the induction of RSV
specific CD8+ T cells in BALB/c mice.
Lack of DNGR-1 reduces RSV-specific CD8+ T cells
after exposure to dead virus-infected cells
In order to assess whether DNGR-1 can have any impact on
the induction of anti-RSV CD8+ T cells, mice were inoculated
intranasally with UV-treated, RSV-infected human epithelial cell
line 2 (HEp-2 cells). Using this model, we minimized the direct
infection of DCs and increased the likelihood that any anti-RSV
CD8+ T-cell responses resulted from cross-presentation of the
inoculum. There was no weight loss detected in any of the groups
after inoculation with infected dead cells (UV-RSVHEp-2; data not
shown) and the number of total cells and CD8+tetramer+ cells in
the lung were similar in DNGR-1 KO andWTmice (Fig. 6A and B).
However, fewer cells were found extravasating into the airways of
DNGR-1 KO mice compared with WT controls as determined by
BAL analysis (Fig. 6C). The number of RSV-specific CD8+ T cells
in BAL was also reduced (Fig. 6D) and lower levels of IFN-γ in
bronchoalveolar lavage fluid (BALF) were found in DNGR-1 KO
mice compared withWTmice (Fig. 6E). We conclude that DNGR-1
deficiency can impact on anti-RSV immunity induced by intranasal
immunization with dead infected cells.
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Figure 2. Weight loss and T-cell infiltration into the lungs are not dependent on DNGR-1. Mice were intranasally infected with 106 FFU of RSV on
day 0. Uninfected WT or DNGR-1 KO mice (Naı¨ve; Na) were used as controls and received an equivalent volume of PBS. (A) Weight was recorded
daily until day 8. The percentages of the weight compared with the original weight (%) on day 0 were calculated. Data are presented as the
mean ± SEM (n = 4–5 mice per group) and are from a single experiment representative of four independent experiments. (B) Total lung cells
were quantified in WT and DNGR-1 KO mice. Data are shown as mean + SEM of 10–15 mice per group, pooled from three individual experiments.
(C) Representative plots of nondebris (SSC-A vs FSC-A), singlet (FSC-W vs SSC-A), live (Dead cells vs. SSC-A) cells analyzed for expression of CD3 and
CD19. CD3+ cells were further gated on CD4 and CD8 expression. Frequencies and absolute numbers of (D) CD4+ T cells and (E) CD8+ T cells were
determined by flow cytometry on day 0 and 8 after RSV infection. Data are presented as mean + SEM of 4–5 mice per group from one experiment
representative of three independent experiments. There were no significant differences between the groups using unpaired, two-tailed, unpaired
Mann–Whitney test.
Discussion
CD8+ T cells are an important part of the immune response against
RSV infection. They are important for viral clearance but at the
same time can contribute to immunopathology, at least in mouse
models. It is not clear to what extent cross-presentation of viral
antigens from dead cells contributes to the CD8+ T-cell response
during respiratory infections. As RSV is cytopathic and can cause
syncytia formation in epithelial cells, we wanted to investigate
whether RSV-triggered cell death is important for the initiation of
CD8+ T-cell responses. One way to address this issue is to use mice
lacking DNGR-1, which is known to bind to the actin cytoskeleton
from damaged cells and ferry associated antigens into the cross-
presentation pathway [33]. DNGR-1+CD103+ DCs are present in
the lung and are thought to be one of the main migratory lung
DC populations [7, 10, 11, 34, 35]. In previous studies, DNGR-1
KO mice were shown to be defective in mounting specific CD8+
T-cell responses to cytopathic lung infection with herpes simplex
virus 1 (HSV-1) or skin infection with vaccinia virus [23, 24].
Notably, we show a dependence on DNGR-1 for the RSV-specific
CD8+ T cells in the airways when mice are inoculated with UV-
killed RSV-infected cells. This demonstrates that DNGR-1 can play
a role in the anti-RSV response if the lung is exposed to infected
dead cell material but, interestingly, we only detect a difference
in number of RSV-specific CD8+ T cells in the airways (BAL) and
not in the lung tissue. This could be due to a decreased inflamma-
tion of the lungs of DNGR-1 KO mice with less infiltration of cells
into the airways or that RSV-specific CD8+ T cells in WT mice are
more activated and have the ability to migrate into the airways.
Independently of these considerations, we found that DNGR-1 is
dispensable for the anti-RSV CD8+ T-cell response in the lungs
during live virus infection. This is in contrast to what has been
found during HSV-1 lung infection [23]. It is possible that the
quantity of virally infected dead cell material and/or the host cell
for viral replication differ during RSV and HSV infection and there-
fore the two models differentially depend on cross-presentation
via DNGR-1 for mounting CD8+ T-cell responses. Alternatively,
or in addition, the rapid decrease of CD103+ DC from the lung
early after RSV infection [7] may lead to the contribution of this
DC subset, and, consequently, the contribution of DNGR-1, being
C© 2014 The Authors. European Journal of Immunology published by
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Figure 3. Quantification of RSV-specific (M2 Tetramer+) CD8+ T cells
from RSV-infected DNGR-1 KO andWTmice. DNGR-1 KO andWTmice
were infected with 106 FFU RSV. Mice were sacrificed on day 8 and lung
cells were stained with MHC class I tetramer complexes specific for
the RSV epitope KdM282-90 and analyzed by flow cytometry. (A) Repre-
sentative plots for the various groups examined on day 0 (Naı¨ve) and
day 8 post RSV infection. CD3+CD19− cells expressing M2 Tetramer and
CD8 are shown. (B) Quantification of the percentages of RSV KdM282-90
specific CD8+ T cells of total CD8+ T cells. Each symbol represents an
individual mouse and data are shown as mean ± SEM of 6–11 mice per
group, pooled from two to three individual experiments. Differences
were not statistically significant using unpaired, two-tailed, unpaired
Mann–Whitney test.
negligible. It will be interesting to address this point by using
BALB/c mice selectively lacking CD103+ and CD8α+ DCs.
Overall, our data show that cross-presentation of RSV
infected dead cell material via DNGR-1 is not a major pathway
for initiating the CD8+ T-cell response during RSV infection.
We cannot exclude the possibility that cross-presentation via
DNGR-1 might contribute to the priming of a small popu-
lation of CD8+ T cells specific for epitopes other than the
three studied here. It is also still possible that other, DNGR-1-
independent routes of cross-presentation are important.
Nevertheless, the results from this study suggest that DNGR-1 is
not a major player in the initiation of RSV immunity and help our
understanding of the basic biology behind immunity to this virus.
Materials and methods
Mice, virus stocks, and infection
Clec9agfp/gfp (DNGR1-deficient) mice [22] were kindly provided
by C. Reis e Sousa (Cancer Research UK London Research Insti-
tute, London, UK). These were backcrossed six generations onto
a BALB/c background, then bred and housed in specific-pathogen
free conditions according to the UK Home Office guidelines.
Clec9a+/+ (wild type) and Clec9a+/gfp (heterozygous) littermates
or age and sex-matched WT BALB/c mice purchased from Harlan
Laboratories (UK) or Charles River Laboratories (UK) were used as
controls. No differences were ever noticed between these control
groups and are all therefore referred to as WT mice.
Figure 4. Peptide-specific CD8+ T-cell responses in
DNGR-1KOandWTmice during RSV infection. Lung cells
of WT and DNGR-1 KOmice (naive (Na) or day 8 post RSV
infection) were restimulated with RSV M282-90 peptide
for 4 h. Intracellular IFN-γ was detected in CD8+ T cells
using flow cytometry. (A) Representative plots of CD3+
CD19− cells expressing IFN-γ and CD8 for the various
groups examined on day 8 p.i. (B) Quantification of the
frequency of CD8+ T cells producing IFN-γ on day 8 p.i.
Each symbol represents an individual mouse and data
are shown asmean± SEM of 8–13mice per group, pooled
from three to four individual experiments. (C) Levels of
IFN-γ in the BAL fluid were determined using ELISA. Data
are presented as the mean ± SEM of 6-8 mice per group,
pooled from two experiments. Differences were not sta-
tistically significant using unpaired, two-tailed, unpaired
Mann–Whitney test.
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Figure 5. Production of IFN-γ by RSV-specific CD8+ T cells in response
to RSV peptides M282-90, F85–93, F92-106, and RSV. Lung cells from DNGR-1
KO and WT mice on day 8 post RSV infection were restimulated with
(A) the immunodominant M282-90, the control (Ctrl) irrelevant M187–195
peptide and RSV (MOI = 1) for 3 days. Supernatants were quantified for
levels of IFN-γ protein by ELISA. Each symbol represents an individual
mouse and data are shown as mean ± SEM of 9–21 mice per group,
pooled from two to five individual experiments. (B) Lung cells were re-
stimulatedwith the subdominant F85–93 and F92–106 peptides (500 ng/mL)
for 3 days. Supernatants were quantified for levels of IFN-γ protein
by ELISA. Each symbol represents an individual mouse and data are
shown as mean ± SEM of 6–8 mice per group, pooled from two indi-
vidual experiments. Differences were not statistically significant using
unpaired, two-tailed, unpaired Mann–Whitney test.
Plaque-purified human RSV (A2 strain from ATCC) was grown
to a high titer in HEp-2 cells. Seven- to ten-week old Clec9agfp/gfp,
Clec9a+/gfp, Clec9a+/+, and WT BALB/c mice were lightly anes-
thesized with isofluorane and challenged intranasally (i.n.) with
a dose of 1 × 106 FFU of RSV on day 0.
To prepare UV-killed RSV-infected HEp-2 cells, 80% confluent
HEp2 cells were infected with RSV at an MOI of 0.5 in serum-
free media (Dulbecco’s Modified Eagle medium (DMEM) supple-
mented with 2 mM L-glutamine). After 2 h incubation at 37°C,
serum-containing media (DMEM supplemented with 10% fetal
bovine serum and 2 mM L-glutamine) was added. Infected cells
were harvested after 24 h, washed and resuspended in sterile PBS
and UV-killed using 750 mJ/cm2 treatment twice in a CX-2000
UV cross-linker (UVP). Cells were further rested for 2 h at room
temperature (RT) and mice were then inoculated i.n. with 2 × 106
UV-killed RSV-infected HEp-2 cells.
Cell isolation and processing
Mice were culled using a fatal dose of pentobarbital injected
intraperitonially (i.p.) according to UK home office guidelines.
BAL was collected by flushing the lungs three times with 1 mL
of PBS supplemented with 0.5 mM EDTA (Life Technologies).
Lung lobes were collected and digested with Collagenase D
(1 mg/mL, Roche) and DNase I (30 μg/mL; Sigma-Aldrich) using
a gentleMACs cell dissociator (Miltenyi Biotech) according to the
manufacturer’s protocol and incubated at 37°C for 30 min. Red
blood cells were lysed by treating lung cells with ACK lysing buffer
and lung cells were passed through 100 μM cell strainers to create
single-cell suspensions. Total cell counts were determined using
hemocytometer slides and dead cells were excluded by Trypan
blue staining (Sigma-Aldrich). To determine the cellular com-
position in the BAL, cells were transferred onto a microscope
slide (Thermo Scientific, UK) using a Shandon Cytospin 3 Cen-
trifuge and slides were stained with hematoxylin and eosin (H&E;
Reagena, Gamidor, UK). Cells were categorized as macrophages,
lymphocytes, neutrophils, and eosinophils based on their morphol-
ogy and size under a light microscope.
Flow cytometry
For flow cytometry analysis, dead cells were discriminated using
LIVE/DEAD Fixable Aqua Dead Cell Stain (Molecular Probes, Life
Technologies) according to the manufacturer’s instruction. Cells
were then incubated in FACS Staining Buffer (PBS containing 1%
BSA and 5 mM EDTA) with antibody recognizing Fcγ II/III recep-
tor (CD16/CD32; BD Biosciences). Surface receptor staining was
performed using the following antibodies, all purchased from BD
Bioscience unless otherwise stated: PE-Cy7- conjugated anti-CD3
(clone 145–2C11); allophycocyanin-H7 or allophycocyanin-Cy7
conjugated anti-CD4 (clone GK1.5); AlexaFluor 700 conjugated
anti-CD8a (clone 53–6.7); and FITC conjugated anti-CD19 (clone
1D3, eBioscience) in FACS Staining Buffer.
Biotinylated RSV M282-90 peptide monomers (H-2Kd/
SYIGSINNI) were obtained from the NIH Tetramer Core Facility
(Emory University Atlanta, GA, USA) and tetramerization was per-
formed in-house using allophycocyanin-conjugated Streptavidin
(Molecular Probes) using a protocol provided by the NIH Tetramer
Core Facility. M2 tetramer staining was performed on lung and
BAL cells following Fc block steps and prior to surface receptor
staining. Cells were incubated with APC-conjugated M2 tetramer
in FACS staining buffer for 30 min in the dark at RT. Cells were
fixed for 30 min in BD Cytofix/Cytoperm fixation buffer at 4°C,
washed and then analyzed on the flow cytometer.
For intracellular detection of IFN-γ, lung cells were stimu-
lated in 96-well plates with 2 μg/mL of the immunodominant
RSV M282-90 peptide (H-2Kd/SYIGSINNI; Synthetic Biomolecules,
San Diego, CA, USA) or the irrelevant M187–195 peptide (H-2Db/
NAITNAKII; Synthetic Biomolecules, San Diego, CA, USA) iden-
tified to be immunodominant in C57BL/6 (H-2Db) mice [5] in
complete DMEM (cDMEM; supplemented with 10% fetal bovine
serum, 2 mM L-glutamine, 100 U/mL penicillin and 100 μg/mL
streptomycin). After 1 h incubation, monensin (Golgi Stop, BD)
was added. Cells were incubated a further 3 h, washed and incu-
bated with live-dead fixable stain, Fcγ II/III receptor and surface
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Figure 6. DNGR-1 is important for induction of RSV-specific CD8+ T cells responses after intranasal dead cell inoculation. DNGR-1 KO andWTmice
were inoculated with 2 × 106 UV-irradiated, RSV-infected HEp-2 cells (UV-RSV HEp-2). Mice were sacrificed on day 8 and airway (BAL) and lung cells
were enumerated and stained with MHC class I tetramer complexes specific for the RSV epitope KdM282-90 and analyzed by flow cytometry. (A) The
total number of lung cells was quantified in naı¨ve or UV-RSV HEp-2 inoculatedmice. (B) Quantification of the total number of RSV KdM282-90 specific
CD8+ T cells in the lung of naı¨ve or UV-RSV HEp-2 inoculated mice. (C) The total number of BAL cells was quantified in naı¨ve or UV-RSV HEp-2
inoculatedmice. (D) Quantification of the total number of RSV KdM282-90 specific CD8+ T cells in the BAL of naı¨ve or UV-RSV HEp-2 inoculatedmice.
(E) Levels of IFN-γ in the BAL fluid were determined using ELISA. Each symbol represents an individual mouse and data are shown as mean ± SEM
of 6–10 mice pooled from two individual experiments except in (B) were data are presented as the mean ± SEM (n = 4–5 mice per group) and are
from a single experiment representative of two independent experiments. ***p  0.001, *p  0.05, unpaired, two-tailed, unpaired Mann–Whitney
test.
receptor antibodies as described above. Intracellular cytokine
staining was performed using the Cytofix/Cytoperm kit (BD)
according to manufacturer’s instructions. Briefly, cells were fixed
in BD Cytofix/Cytoperm buffer for 30 min at 4°C, washed with
FACS staining buffer and then incubated with Fcγ II/III recep-
tor (CD16/CD32) antibody in BD Perm Wash Buffer for 15 min.
Cells were then incubated with PE-conjugated anti-IFN-γ antibody
(clone XMG1.2, BD biosciences) in Perm Wash buffer for 1 h at
4°C, washed and transferred to FACS staining buffer for analy-
sis. Cells were acquired on the LSR Fortessa flow cytometer (BD)
and data were analyzed using Flowjo Software (Version 9.6.4).
Cells were gated for nondebris, live cells, and singlets and then
analyzed for indicated markers.
Gene Expression
Total RNA was extracted from homogenized lung tissue using
TRIzol RNA Isolation reagent in combination with a chloroform
separation, followed by washes with isopropanol and 75% ethanol
as per the protocol provided (TRIzol Reagent, Ambion, Life Tech-
nologies, UK). RNA purity and concentration was determined
using the Nanodrop 1000 (Thermo Scientific) and 1–2 μg of total
RNA was reverse-transcribed to cDNA using the high capacity
RNA-to-DNA kit according to the manufacturer’s instructions
(Invitrogen, Life Technologies). Real-time quantitative PCR was
performed to determine mRNA levels of RSV L gene using primers
(Invitrogen) and probes (Eurofins) [36]. Results were normalized
to Gapdh (Applied Biosystems) and the exact copy numbers of L
gene was calculated using an internal plasmid standard to give an
absolute quantification. Analysis was performed using the Quanti-
tect Probe PCR Master Mix (Qiagen) and the 7500 Fast Real-time
PCR System (Applied Biosystems).
Chemokine and cytokine protein detection
To quantify RSV-specific IFN-γ levels from infected lung
cells, 4 × 105 cells/well in 96-well round-bottomed
plates were stimulated with either RSV (MOI of 1) or
RSV M282-90 (H-2Kd/SYIGSINNI), F85–93 (H-2Kd/KYKNAVTEL),
F92–106 (H-2Kd/ELQLLMQSTPPTNNR) or control M187–195
(H-2Db/NAITNAKII) peptide in indicated concentrations (Syn-
thetic Biomolecules, San Diego, CA, USA) in cDMEM for 72 h at
37°C. Supernatants were assayed using an IFN-γ ELISA kit (R&D
Systems) according to the manufacturer’s instructions.
Levels of IL-6, CXCL10 (IP-10) and IFN-γ protein were
measured in the BAL fluid using ELISA kits and following the
C© 2014 The Authors. European Journal of Immunology published by
Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
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manufacturer’s instructions (all from R&D Systems). IFN-α levels
in the BAL were measured by ELISA as previously described [37].
Data was acquired on a SpectraMax Plus plate reader (Molecular
Devices) and analyzed using SoftMax software (version 5.2).
Statistical analysis
Results are presented as mean ± SEM. Statistical significance
was determined using a two-tailed, unpaired, nonparametric
Mann–Whitney t-test (*p  0.05, **p  0.01, ***p  0.001).
Values of p < 0.05 were considered significant (Prism software;
Graph-Pad Software Inc.).
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